Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Vaxil Bio Ltd V.VXL

Alternate Symbol(s):  VXLLF

Vaxil Bio Ltd. is a Canada-based biotechnology company. The Company is focused on a drug discovery and development platform based on Signal Peptides (SPs) which the Company deploys to fight infectious diseases and cancer. The Company’s most advanced product, ImMucin, a MUC1 SP-derived vaccine, completed a Phase I/II clinical trial in multiple myeloma. The Company also has a SP-based COVID-19 vaccine candidate and a SP-based tuberculosis vaccine / treatment candidate. In addition, The Company has mAb candidates for the treatment of oncology and infectious diseases to be used alone, and in combination with other treatments. It has also initiated a pre-clinical program for a drug delivery polymer that targets high affinity E-selectin (P-Esbp), which the Company licensed for development and commercialization from BGN Technologies. It exploits the properties of SP domains on crucial proteins to develop targeted therapies against cancer targets and infectious disease pathogens.


TSXV:VXL - Post by User

Comment by 90guppyon Dec 08, 2020 2:14pm
58 Views
Post# 32059411

RE:RE:RE:RE:VAXIL PRIVATE OFFERING

RE:RE:RE:RE:VAXIL PRIVATE OFFERINGThis is a bet whether USAMRIID test produces positive data or not, that is all there is. It is in the hands of USAMRIID now. Nothing else to divulge or say that will affect the experiment, nothing.



Charleyfarley wrote:
Unfortunately it seems the company have not been up front with its retail base in respect to the experiments hence the corvax experiment seemingly being a lengthier process. I have this from an accurate source who will remain anon. Maybe Mr Goren should have put his energy into the job at hand job rather than his own personal agenda . He will be judged by his Peers as the man who let an immense opportunity slip from his grasp and not a man who could have written his own Destiny .


<< Previous
Bullboard Posts
Next >>